{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Rockaway",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65461",
      "recalling_firm": "Warner Chilcott US LLC",
      "address_1": "100 Enterprise Dr",
      "address_2": "N/A",
      "postal_code": "07866-2116",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-822-2013",
      "product_description": "Enablex (darifenacin) Extended Release Tablet, 15 mg per tablet.  Physician Sample 7 Tablets bottle, Rx only,  Mfd by:  Novartis Pharma Stein AG, Stein, Switzerland, NDC 0078-9420-07",
      "product_quantity": "188,600 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: unspecified degradation product",
      "recall_initiation_date": "20130517",
      "center_classification_date": "20130726",
      "termination_date": "20151130",
      "report_date": "20130807",
      "code_info": "Lot F1002 - Exp.12/13",
      "more_code_info": ""
    }
  ]
}